Consensus statement regarding OKT3-induced cytokine-release syndrome and human antimouse antibodies.
Norman
D J
DJ
Laboratory of Immunogenetics and Transplantation, Oregon Health Sciences University, Portland 97201.
Chatenoud
L
L
Cohen
D
D
Goldman
M
M
Shield
C F
CF
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000096:biosynthesis; D000917:Antibody Formation; D002493:Central Nervous System Diseases / Q000209:etiology* / Q000517:prevention & control; D016207:Cytokines / Q000378:metabolism / Q000502:physiology*; D006801:Humans; D051379:Mice; D016853:Muromonab-CD3 / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use*; D013577:Syndrome
D000888:Antibodies, Anti-Idiotypic; D016207:Cytokines; D016853:Muromonab-CD3